NIFTY 50▲22,147.00
151.15 (0.69%)
SENSEX▲73,088.33
599.34 (0.83%)
NIFTY BANK▲47,574.15
504.70 (1.07%)
TATA MOTORS▼963.20
-8.15 (-0.84%)
INDIAN RAILWAY FINANCE CORP▼141.00
-0.95 (-0.67%)
SUZLON ENERGY▼39.35
-1.80 (-4.37%)
TATA POWER▼428.10
-1.65 (-0.38%)
TATA STEEL▲162.10
2.05 (1.28%)
YES BANK▲23.95
0.05 (0.21%)
INDIAN RENEWABLE ENERGY▼160.70
-2.45 (-1.50%)
RELIANCE INDUSTRIES▲2,940.25
11.60 (0.40%)
RELIANCE POWER▼28.05
-0.65 (-2.26%)
HDFC BANK▲1,531.30
36.60 (2.45%)
RAIL VIKAS NIGAM▼258.45
-1.45 (-0.56%)
VODAFONE IDEA▼12.90
-0.30 (-2.27%)
JIO FIN SERVICES LTD▼370.10
-8.30 (-2.19%)
ADANI POWER▼594.55
-3.55 (-0.59%)
ZOMATO▲189.20
4.00 (2.16%)
NHPC▼87.15
-2.35 (-2.63%)
INDIAN RAILWAY TOURISM CORP▼992.00
-0.95 (-0.10%)
STATE BANK OF INDIA▲750.45
5.65 (0.76%)
INDIAN OIL CORP▼166.65
-2.35 (-1.39%)
MRF▼1,29,157.65
-73.85 (-0.06%)
ITC▲424.75
5.90 (1.41%)
ADANI GREEN ENERGY▼1,770.05
-5.40 (-0.30%)
ADANI ENTERPRISES▲3,026.95
7.65 (0.25%)
JAIPRAKASH POWER VENTURES▼17.05
-0.15 (-0.87%)
ADANI PORT & SEZ▲1,310.00
14.45 (1.12%)
Sun Pharma Advanced Research Share Price
SPARC
₹332.55-₹17.50 (-5%) Past YearLast updated on 19 Apr, 2024 | 03:54 PM IST
₹332.55₹332.55
LH
What’s in news?
Company overview
About
Market cap
| Open₹332.55 | Close₹350.05 |
Circuit range₹367.55 - ₹332.55 | Day range₹332.55 - ₹332.55 | Year range₹178.80 - ₹472.80 |
Volume63,338 | Avg. traded₹332.55 | Revenue (12m)₹107 Cr |
Sun Pharma Advanced ResearchSun Pharma Advanced Research Company Limited is an India-based clinical-stage bio-pharmaceutical company. The Company is in the business of research and development (R&D) of pharmaceutical products to unmet medical needs in the areas of oncology, neurodegeneration and immunology. The Company develops New Chemical Entities (NCE), New Biological Entities and reformulated products. Its NCE includes SCC-138, SCO-088, SCO-120 and SCD-044. Its Novel Drug Delivery Systems (NDDS) include Wrap Matrix Technology, Lipexelle technology and TearAct Technology. Wrap Matrix technology is useful to develop controlled release tablets. It has developed Elepsia XR using Wrap MatrixTM technology. Lipexelle technology for ophthalmic formulations. It has also developed Xelpros, a BAK free latanoprost eye drop developed using Lipexelle technology. Xelpros is commercialized by its partner in the United States. It has also developed PDP-716 eye drops for treatment of Glaucoma based on its TearAct technology.
Read more
Sun Pharma Advanced Research Key indicators
52 week high₹472.80 | 52 week low₹178.80 | P/E ratio-99999.99 |
P/B ratio | ROE-143.72% | ROCE-69.44% |
Dividend yield-- | Debt/Equity ratio | EPS-6.86 |
Learn more
Featured in
Investment checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin-85.09% | Net profit margin-93.22% |
ROE-143.72% | ROA-40.1% |
ROCE-69.44% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Sun Pharma Advanced Research Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Apr 18 2024 | ₹350.05 | ₹350.05 | ---% |
Tue, Apr 16 2024 | ₹368.45 | ₹368.45 | ---% |
Mon, Apr 15 2024 | ₹387.85 | ₹387.85 | ---% |
Fri, Apr 12 2024 | ₹408.25 | ₹408.25 | ---% |
Wed, Apr 10 2024 | ₹429.70 | ₹429.70 | ---% |
Tue, Apr 9 2024 | ₹472.80 | ₹452.30 | -4.53% |
Mon, Apr 8 2024 | ₹455.30 | ₹455.30 | ---% |
Fri, Apr 5 2024 | ₹419.00 | ₹433.65 |
Events
No data available at the moment